4//SEC Filing
Morano Susan E 4
Accession 0001225208-23-007373
CIK 0000885725other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 4:57 PM ET
Size
13.1 KB
Accession
0001225208-23-007373
Insider Transaction Report
Form 4
Morano Susan E
Director
Transactions
- Award
Deferred Stock Units
2023-07-03+456→ 2,082 total→ Common Stock (456 underlying) - Award
Common Stock
2023-07-03+456→ 2,082 total - Award
Common Stock
2023-07-03+1,626→ 1,626 total - Award
Deferred Stock Units
2023-07-03+1,626→ 1,626 total→ Common Stock (1,626 underlying)
Footnotes (5)
- [F1]Grant of restricted stock to non-employee director following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2024 annual meeting of stockholders. The grant of restricted stock vests in full upon the next annual meeting of stockholders. Reflects a value of approximately $87,094.25 (representing 50% of the prorated amount of the non-employee director compensation program's annual equity award having a value of $205,000) divided by the closing price of common stock on the date of grant.
- [F2]Grant of restricted stock in lieu of 25% yearly cash compensation, following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2024 annual meeting of stockholders. Reflects a value of approximately $24,428.88 (representing 25% of the prorated amount of the non-employee director compensation program's cash retainer having a value of $115,000) divided by the closing price of the common stock on the date of grant.
- [F3]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- [F4]Grant of deferred stock units to non-employee director following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2024 annual meeting of stockholders. The grant of deferred stock units vests in full upon the next annual meeting of stockholders. Reflects a value of approximately $87,094.25 (representing 50% of the prorated amount of the non-employee director compensation program's annual equity award having a value of $205,000) divided by the closing price of the common stock on the date of grant. Vested shares will be issued to the reporting person following the reporting person's separation from Board of Director service, in accordance with the Company's Non-Employee Director Deferred Compensation Plan.
- [F5]Grant of deferred stock units in lieu of 25% yearly cash compensation following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2024 annual meeting of stockholders. The grant of deferred stock units vests in full upon the next annual meeting of stockholders. Reflects a value of approximately $24,428.87 (representing 25% of the prorated amount of the non-employee director compensation program's cash retainer having a value of $115,000) divided by the closing price of the common stock on the date of grant. Vested shares will be issued to the reporting person following the reporting person's separation from Board of Director service, in accordance with the Company's Non-Employee Director Deferred Compensation Plan.
Documents
Issuer
BOSTON SCIENTIFIC CORP
CIK 0000885725
Entity typeother
Related Parties
1- filerCIK 0001983791
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 4:57 PM ET
- Size
- 13.1 KB